PDF(902 KB)
PDF(902 KB)
PDF(902 KB)
我国医学卫生健康事业投入的现状、问题与对策
Current Status, Problems, and Countermeasures of Health Investment in China
本文围绕我国医学卫生健康事业的投入现状、存在问题及发展对策展开深入分析。通过系统阐述健康劳动力与健康产业在推动经济增长中的重要作用，指出发展医学卫生健康事业及健康产业不仅保障了民众的福祉，还是促进经济社会高质量发展的关键因素。本文对医学卫生健康事业投入的规模与结构进行横向与纵向比较，显示相比于国际水平，我国仍存在卫生总费用占GDP比重待提升、政府卫生投入待提高及筹资结构待优化等问题。据此，本文建议：转变对医学卫生健康事业投入的传统观念，强化社会对医学卫生健康事业投入重要性的认识，将医学卫生健康事业发展目标纳入有关考核；加大对医学卫生健康事业投入的规模，建立稳定、可持续、多元的政府卫生投入机制，整合多元、多形式的社会资源，拓宽卫生筹资渠道；提升医学卫生健康事业投入的效率，建立以人群健康指标为导向的投入、监督和评价机制，促进医学卫生健康事业治理现代化。文章呼吁高度重视医学卫生健康事业在经济发展中的重要作用，以实现健康与经济的协同发展。
This study analyzes the status, issues, and strategies of investment in China's medical and health sector. It underscores the critical role of a healthy workforce and health industry in driving economic growth, noting their importance for both public welfare and high-quality socio-economic progress. Through horizontal and vertical comparisons, the study highlights key issues: the low proportion of health expenditure to GDP, insufficient government investment, and an underdeveloped financing structure relative to international standards. Based on these findings, the study recommends: (1) shifting traditional perspectives on health investment to emphasize its critical importance, and incorporating health sector development goals into relevant performance evaluations; (2) increasing the scale of investment, establishing a stable, sustainable, and diversified government funding mechanism, integrating various forms of social resources, and expanding health financing channels; (3) enhancing investment efficiency by adopting a population health indicator-based framework for investment, monitoring, and evaluation, thereby advancing health governance modernization. The study advocates for positioning the medical and health sector at the core of economic development to achieve a synergistic advancement of health and the economy.
群医学 / 卫生经济 / 医学卫生健康事业投入 / 健康产业 / 宏观效率
population medicine / health economics / health investment / health industry / macro-level efficiency
| [1] |
Peng W, Chen S Q, Chen X G, et al. Trends in major non-communicable diseases and related risk factors in China 2002—2019: An analysis of nationally representative survey data [J]. The Lancet Regional Health Western Pacific, 2023, 43: 100809.
|
| [2] |
全国老龄工作委员会办公室. 2022年度国家老龄事业发展公报 [EB/OL]. (2023-12-14)[2024-03-17]. https://www.gov.cn/govweb/lianbo/bumen/202312/content_6920261.htm.
The National Working Commission on Aging. 2022 national communique on the development of aging [EB/OL]. (2023-12-14)[2024-03-17]. https://www.gov.cn/govweb/lianbo/bumen/202312/content_6920261.htm.
|
| [3] |
国家统计局. 2023年国民经济回升向好 高质量发展扎实推进[EB/OL]. (2024-01-17)[2024-03-17]. https://www.stats.gov.cn/sj/zxfb/202401/t20240117_1946624.html.
National Bureau of Statistics. Solid progress will be made in the recovery of the national economy and high-quality development in 2023 [EB/OL]. (2024-01-17)[2024-03-17]. https://www.stats.gov.cn/sj/zxfb/202401/t20240117_1946624.html.
|
| [4] |
刘喜梅. 大医学 大卫生 大健康——全国政协常委、中国医学科学院院长、北京协和医学院校长王辰访谈 [N]. 人民政协报, 2022-03-08(22).
Liu X M. “Great medicine, great health, great well-being”: Inter view with Wang Chen, member of the National Committee of the Chinese People's Political Consultative Conference, President of the Chinese Academy of Medical Sciences & Peking Union Medical College [N]. People's Political Consultative Daily, 2022-03-08(22).
|
| [5] |
Wang C, Chen S, Shao R, et al. Redefining human health: Physical wellbeing, mental wellbeing, social wellbeing, and environmental wellbeing [J]. Chinese Medical Journal, 2023, 136(20): 2395‒2396.
|
| [6] |
The World Bank. Current health expenditure (% of GDP) [EB/OL]. (2024-01-19)[2024-03-17]. https://data.worldbank.org/indicator/SH.XPD.CHEX. GD.ZS.
|
| [7] |
国家卫生健康委员会. 中国卫生健康统计年鉴 (2022) [M]. 北京: 中国协和医科大学出版社, 2022.
National Health Commission of the People's Republic of China. China health statistics yearbook (2022) [M]. Beijing: Peking Union Medical College Press, 2022.
|
| [8] |
World Health Organization. Health for all: Transforming economies to deliver what matters: Final report of the WHO council on the economics of health for all [EB/OL]. (2023-05-23)[2024-03-17]. https://www.who.int/publications/i/item/9789240080973.
|
| [9] |
Jamison Dean T, Gelband H, Susan H, et al. Disease control priorities (Third edition) [EB/OL]. (2017-12-06)[2024-03-17]. https://openknowledge.worldbank.org/entities/publication/62cb9c2b-25dc-5329-9855-2b35dcb0f44a.
|
| [10] |
Castillo-Zunino F, Keskinocak P, Nazzal D, et al. Health spending and vaccination coverage in low-income countries [J]. BMJ Global Health, 2021, 6(5): e004823.
|
| [11] |
Jayachandran S, Lleras-Muney A. Life expectancy and human capital investments: Evidence from maternal mortality declines [J]. The Quarterly Journal of Economics, 2009, 124(1): 349‒397.
|
| [12] |
Cole M A, Neumayer E. The impact of poor health on total factor productivity [J]. The Journal of Development Studies, 2006, 42(6): 918‒938.
|
| [13] |
唐钧. 大健康与大健康产业的概念、现状和前瞻——基于健康社会学的理论分析 [J]. 山东社会科学, 2020 (9): 81‒87.
Tang J. The concept, status, and prospect of massive health and massive health industry: A theoretical analysis based on sociology of health [J]. Shandong Social Sciences, 2020 (9): 81‒87.
|
| [14] |
张车伟, 赵文, 程杰. 中国大健康产业: 属性、范围与规模测算 [J]. 中国人口科学, 2018 (5): 17‒29, 126.
Zhang C W, Zhao W, Cheng J. China's a great-health industry: Property, scope and market size [J]. Chinese Journal of Population Science, 2018 (5): 17‒29, 126.
|
| [15] |
陆杰华. 做优做强健康产业的策略选择 [EB/OL]. (2023-01-01)[2024-03-17]. http://paper.people.com.cn/rmlt/html/2023-01/01/content_25966110.htm.
Lu J H. The strategic choice of better and stronger health industry[EB/OL]. (2023-01-01)[2024-03-17]. http://paper.people.com.cn/rmlt/html/2023-01/01/content_25966110.htm.
|
| [16] |
Frankovic I, Kuhn M. Health insurance, endogenous medical progress, health expenditure growth, and welfare [J]. Journal of Health Economics, 2023, 87: 102717.
|
| [17] |
国家统计局. 2022年全国科技经费投入统计公报 [EB/OL]. (2023-09-18)[2024-03-17]. https://www.stats.gov.cn/sj/zxfb/202309/t20230918_1942920.html.
National Bureau of Statistics. Statistical bulletin of national science and technology funding in 2022 [EB/OL]. (2023-09-18)[2024-03-17]. https://www.stats.gov.cn/sj/zxfb/202309/t20230918_1942920.html.
|
| [18] |
OECD Main Science and Technology Indicators and Research and Development Statistics Databases. Health at a glance 2023 [EB/OL]. (2023-11-07)[2024-03-17]. https://stat.link/x6f02a.
|
| [19] |
Baumol W J. The cost disease: Why computers get cheaper and health care doesn't [M]. New Haven: Yale University Press, 2012.
|
| [20] |
娄成武, 于慧. 我国的积极老龄化策略: 认知转向、现实挑战与实践进路 [J]. 社会科学辑刊, 2024 (1): 181‒190.
Lou C W, Yu H. China's active aging strategy: Cognitive turn, realistic challenge and practical approach [J]. Social Science Journal, 2024 (1): 181‒190.
|
| [21] |
Chen S M, Li L Y, Jiao L R, et al. Long-term care insurance and the future of healthy aging in China [J]. Nature Aging, 2023, 3(12): 1465‒1468.
|
| [22] |
人民日报. 我国主要健康指标居中高收入国家前列 人民健康水平显著提升 [EB/OL]. (2023-02-26)[2024-03-17]. https://www.gov.cn/xinwen/2023-02/26/content_5743337.htm.
People's Daily. In terms of main health indicators, the health status of Chinese people has been significantly improved [EB/OL].(2023-02-26)[2024-03-17]. https://www.gov.cn/xinwen/2023-02/26/content_5743337.htm.
|
| [23] |
孟庆跃. 政府卫生投入分析和政策建议 [J]. 中国卫生政策研究, 2008, 1(1): 5‒8.
Meng Q Y. Analysis and policy implications of the governmental health investment [J]. Chinese Journal of Health Policy, 2008, 1(1): 5‒8.
|
| [24] |
Chen S M, Kuhn M, Prettner K, et al. Macro-level efficiency of health expenditure: Estimates for 15 major economies [J]. Social Science & Medicine, 2021, 287: 114270.
|
| [25] |
财政部, 国家发展和改革委员会, 民政部, 等. 关于完善政府卫生投入政策的意见 [EB/OL]. (2009-07-01)[2024-03-17]. http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/200907/t20090701_86834.html.
Ministry of Finance of the People's Republic of China,National Development and Reform Commission,Ministry of Civil Affairs of the People's Republic of China, et al. Suggestions on improving government health investment policy [EB/OL]. (2009-07-01)[2024-03-18]. http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/200907/t20090701_86834.html.
|
| [26] |
马瑶, 胡慧美, 高启胜. 2010—2020年公立医院收支结构变化分析 [J]. 中国医院, 2023, 27(2): 17‒21.
Ma Y, Hu H M, Gao Q S. Analysis of changes in revenue and expenditure structure of public hospitals in China from 2010 to 2020 [J]. Chinese Hospitals, 2023, 27(2): 17‒21.
|
| [27] |
国家卫生健康委员会. 2021年度全国二级公立医院绩效考核国家监测分析情况的通报 [EB/OL]. (2023-04-07)[2024-03-17]. http://www.nhc.gov.cn/yzygj/s3594q/202304/0aeb2d80786c4eeca94e7b5 d179a3b4d.shtml.
National Health Commission of the People's Republic of China. Notification of the national monitoring and analysis of the performance appraisal of secondary public hospitals in 2021 [EB/OL]. (2023-04-07)[2024-03-17]. http://www.nhc.gov.cn/yzygj/s3594q/202304/0aeb2d80786c4eeca94e7b5d179a3b4d.shtml.
|
| [28] |
国家卫生健康委员会. 2020年度全国三级公立医院绩效考核国家监测分析情况的通报 [EB/OL]. (2022-07-04)[2024-03-17]. http://www.nhc.gov.cn/yzygj/s3594q/202207/04928bbf79e64bc3a49b22 48f1f97978.shtml.
National Health Commission of the People's Republic of China. Notificaiton of the national monitoring and analysis of the performance appraisal of tertiary public hospitals in 2020 [EB/OL]. (2022-07-04)[2024-03-17]. http://www.nhc.gov.cn/yzygj/s3594q/202207/04928bbf79e64bc3a49b2248f1f97978.shtml.
|
| [29] |
陈春梅, 郭锋, 李岩, 等. 新医改以来我国政府卫生投入评估分析——基于卫生筹资政策分析框架 [J]. 卫生经济研究, 2021, 38(7): 12‒16, 20.
Chen C M, Guo F, Li Y, et al. Evaluation and analysis of Chinese government health investment since the new medical reform—Based on the policy analysis framework of health financing [J].Health Economics Research, 2021, 38(7): 12‒16, 20.
|
| [30] |
杨维中, 冷志伟, 单广良, 等. 群医学: 弥合预防医学与临床医学裂痕的新兴学科 [J]. 中华医学杂志, 2020, 100(26): 2001‒2005.
Yang W Z, Leng Z W, Shan G L, et al.Population medicine: A newly emerging subject healing the schism between preventive medicine and clinical medicine [J].National Medical Journal of China, 2020, 100(26): 2001‒2005.
|
| [31] |
Chen S M, Sudharsanan N, Huang F, et al. Impact of community based screening for hypertension on blood pressure after two years: Regression discontinuity analysis in a national cohort of older adults in China [J]. BMJ, 2019, 366: l4064.
|
| [32] |
Wang C, Qi W, Yang T, et al. The care cascade of chronic obstructive pulmonary disease in China: A cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme [J]. eClinicalMedicine, 2024, 74: 102597.
|
/
| 〈 |
|
〉 |
